异基因造血干细胞移植治疗多发性骨髓瘤

异基因造血干细胞移植治疗多发性骨髓瘤

ID:46140268

大小:2.20 MB

页数:93页

时间:2019-11-21

异基因造血干细胞移植治疗多发性骨髓瘤_第1页
异基因造血干细胞移植治疗多发性骨髓瘤_第2页
异基因造血干细胞移植治疗多发性骨髓瘤_第3页
异基因造血干细胞移植治疗多发性骨髓瘤_第4页
异基因造血干细胞移植治疗多发性骨髓瘤_第5页
资源描述:

《异基因造血干细胞移植治疗多发性骨髓瘤》由会员上传分享,免费在线阅读,更多相关内容在教育资源-天天文库

1、AllogeneichaematopoieticcelltransplantationformultiplemyelomaTheallogeneictransplanthastheadvantageovertheautologoustransplantThegraftdoesnotcontaintumorcellsandthepotentialforagraftversusmyeloma(GvM)effectBonemarrowtransplantationinthreepatientswithmultiplemyelomaGahrtonG,RingdénO,LönnqvistB,L

2、indquistR,LjungmanP.ActaMedScand1986;219(5):523-7.瑞典卡罗林斯卡医学院1983MyeloablativeconditioningThreepatientswithmultiplemyelomareceivedbonemarrowgraftsfromHLA-identicalsiblingdonorsOneofthepatients,withIgAkappamyeloma,refractorytoalkeran-prednisonetherapy,iswellandstillwithoutsignofdisease26monthspos

3、ttransplantationAsecondpatientwithBence-Joneskappamyelomaiswell,andskeletalpainandBence-Jonesproteinuriahasdisappeared2monthsaftertransplantation.AthirdpatientwithIgG-lambdamyelomadiedofeffusivepericarditisshortlyaftertransplantation.ActaMedScand1986;219(5):523-7ConclusionBonemarrowtransplantat

4、ionmaybeindicatedinaselectivegroupofpatientswithmultiplemyelomaActaMedScand1986;219(5):523-7Outof690allogeneticmatchedsiblingdonortransplantsforMM344wereperformedduringtheperiod1983-93(allwithBM)[group1]356during1994-98(223withBMgroup2and133withPBgroup3)themedianageattransplantationofpatientsin

5、group1was43years(range21-62)Ingroup2,44years(range18_57)andingroup3,46years(range25_60)TBI+CYtendedtobemorecommonlyusedingroup1(37%)and2(39%)thaningroup3(27%)Melphalancontainingregimestendedtobemorelyusedingroup3MelphalanorBusulphan+CYrarelyConditiongregimeEngraftmentGVHDTreatment–relatedmortal

6、ityTreatment–relatedmortalityRelapserateRelapserateSurvivalSurvivalProgression–freesurvivalPFSwassignificantlybetterforgroup2thanforgroup1(P<0.0001)Withnosignificantlydifferencebetweengroup2and3Causeofdeath75%ingroup1,36%ingroup2,33%ingroup3GVHDFungalARDSOrganfailureCauseofdeaththestudyshowstha

7、ttheimprovementisentirelyaresultofalowerTRMduringthelatest5-yearsperiodaGVHDhasnochangedduringthisperoidTherewassignificantdifferenceindeathscausedbyIPandbacterialandfungalinfectionConditioningregimeTBI+Melphalanhasnotprevirousbee

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。